DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Zenith Drugs Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 26 Aug·26 Aug 2026, 8:05 am

Zenith Drugs

Zenith Drugs Limited has announced a change in its key management personnel and statutory registrars. The company has informed the stock exchanges about this shift in its leadership and administrative structure.

For retail investors, such changes are generally neutral events. They do not directly impact the company's operational performance or financial health. However, it is important to monitor the new appointees' backgrounds to ensure there are no unforeseen risks.

Investors should watch for any official announcements regarding the specific roles being vacated and filled. This information helps clarify the continuity of business operations and the company's governance standards.